Heart Failure Reversed by Stem Cell Therapy Now in Trials

By Clyde Hughes – Re-Blogged From Newsmax Health

Heart failure could be reversed by a new stem cell therapy now on trial in Britain that could cut out the need for surgery as the treatment revitalizes damaged tissue by cells harvested from the patient’s blood, the Express reported Monday.

Pet Cloning is Bringing Human Cloning a Little Bit Closer

By Antonio Regalado – Re-Blogged From MIT Technology Review

When Barbra Streisand revealed to Variety magazine that she’d had her dog cloned for $50,000, many people learned for the first time that copying pets and other animals is a real business.

That’s right: you can pay to clone a dog, a horse, or a top beef bull and get a living copy back in a matter of months.

Continue reading

Trials For Potential ALS Treatment

By Jonathan Saltzman – Re-Blogged From Boston Globe

As an engineering professor at Lehigh University in Pennsylvania, Richard P. Vinci has run plenty of experiments. He specializes in figuring out what makes materials break, everything from computer chips to microneedles that deliver medicine.

But now the 51-year-old graduate of MIT and Stanford University is the subject of a study himself, one he hopes might save, or at least extend, his life. Vinci, a Reading native, was diagnosed 18 months ago with ALS, the deadly disease that ravages the nervous system and gradually robs patients of the ability to speak, eat, and, finally, breathe.

Continue reading

Stem Cell Transplants Restore 2 Patients’ Vision

Re-Blogged From Newsmax Health

An experimental stem cell therapy restored partial vision to two patients with a common cause of blindness, British doctors reported this week.

Embyronic stem cells were converted into patches of eye cells and grown in the lab. The patches were then inserted into the back of one eye in each of the patients, both of whom suffer from age-related macular degeneration, the BBC News reported.

The transplants, on a woman in her sixties and an 86-year-old man, were performed at Moorfields Eye Hospital in London. A year later, both patients report improved vision in the treated eye.

Another eight more patients are scheduled to take part in the clinical trial of the procedure, reported in the journal Nature Biotechnology.

“We’ve restored vision where there was none,” Lyndon da Cruz, consultant retinal surgeon at Moorfields, told BBC News.

“It’s incredibly exciting. As you get older, parts of you stop working and for the first time we’ve been able to take a cell and make it into a specific part of the eye that’s failing and put it back in the eye and get vision back.”

Da Cruz stopped short of calling the procedure a cure because it does not completely restore normal vision.

CONTINUE READING –>

Longer Life in a Pill May Already Be Available at Your Local Drug Store

By Shelly Fan – Re-Blogged From Singularity Hub

To most of the scientific community, “anti-aging” is a dirty word.

A medical field historically associated with charlatans and quacks, scientists have strictly restricted the quest for a “longevity pill” to basic research. The paradigm is simple and one-toned: working on model organisms by manipulating different genes and proteins, scientists slowly tease out the molecular mechanisms that lead to — and reverse — signs of aging, with no guarantee that they’ll work in humans.

Continue reading

Stem Cell Study Offers New Clues to Reversing Aging

   By Shelly Xuelai Fan – Re-Blogged From Singularity Hub

Continue reading

‘Reprogrammed’ Stem Cells Fight Parkinson’s

Re-Blogged From Newsmax

Scientists have successfully used “reprogrammed” stem cells to restore functioning brain cells in monkeys, raising hopes the technique could be used in future to help patients with Parkinson’s disease.

Since Parkinson’s is caused by a lack of dopamine made by brain cells, researchers have long hoped to use stem cells to restore normal production of the neurotransmitter chemical.

Continue reading